Evaluation of drug interventions for the treatment of sleep disorders in children with autism spectrum disorders: a systematic review.
Autism spectrum disorders
Drug
Meta-analysis
Sleep disorders
Journal
Korean journal of pediatrics
ISSN: 1738-1061
Titre abrégé: Korean J Pediatr
Pays: Korea (South)
ID NLM: 101215374
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
received:
15
06
2019
accepted:
30
09
2019
entrez:
26
11
2019
pubmed:
26
11
2019
medline:
26
11
2019
Statut:
ppublish
Résumé
A structured review study of drug interventions on sleep disorders in patients with autism spectrum disorders (ASD) has not been published to date. This systematic review aimed to investigate drug interventions for the treatment of sleep disorders in children with ASD. The Web of Science, PubMed, and Scopus databases were searched until March 2019. Study quality was assessed using the Delphi checklist. Due to the heterogeneity of the findings, a meta-analysis was not possible. Drug interventions for the treatment of sleep disorders in patients with ASD included melatonin, atomoxetine, and risperidone. Atomoxetine had no effect on sleep disorders in patients with ASD. A total of 10 studies were reviewed. Melatonin appears to be useful for the treatment of sleep problems in patients with ASD, but further studies are needed to determine the effects of other drugs.
Identifiants
pubmed: 31760719
pii: kjp.2019.00668
doi: 10.3345/kjp.2019.00668
pmc: PMC6881205
doi:
Types de publication
Journal Article
Langues
eng
Pagination
405-409Subventions
Organisme : Hamadan University of Medical Sciences
ID : 980210789
Références
J Sleep Res. 2012 Dec;21(6):700-9
pubmed: 22616853
Child Care Health Dev. 2006 Sep;32(5):585-9
pubmed: 16919138
Int J Epidemiol. 2014 Apr;43(2):443-64
pubmed: 24518932
Sleep Med Rev. 2011 Dec;15(6):379-87
pubmed: 21393033
J Child Adolesc Psychopharmacol. 2018 Mar;28(2):130-135
pubmed: 29112459
Dev Med Child Neurol. 2009 May;51(5):340-9
pubmed: 19379289
Korean J Pediatr. 2019 Apr;62(4):126-130
pubmed: 30590001
Dev Med Child Neurol. 2011 Sep;53(9):783-792
pubmed: 21518346
J Clin Epidemiol. 1998 Dec;51(12):1235-41
pubmed: 10086815
J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):948-957.e4
pubmed: 29096777
Sleep Med Rev. 2009 Dec;13(6):403-11
pubmed: 19398354
J Pineal Res. 2008 Jan;44(1):57-64
pubmed: 18078449
Dialogues Clin Neurosci. 2012 Sep;14(3):281-92
pubmed: 23226953
Pediatrics. 2016 Feb;137 Suppl 2:S98-S104
pubmed: 26908483
J Child Adolesc Psychopharmacol. 2005 Dec;15(6):869-84
pubmed: 16379507
J Clin Sleep Med. 2009 Apr 15;5(2):145-50
pubmed: 19968048
J Child Adolesc Psychopharmacol. 2018 Oct 11;:null
pubmed: 30132686
Dev Med Child Neurol. 1998 Mar;40(3):186-92
pubmed: 9566656
J Autism Dev Disord. 2011 Feb;41(2):175-84
pubmed: 20535539
J Pediatr Neurosci. 2015 Oct-Dec;10(4):304-7
pubmed: 26962332
PLoS One. 2015 Aug 28;10(8):e0136540
pubmed: 26317406
Med Sci (Basel). 2018 Oct 25;6(4):null
pubmed: 30366448
Pharmacotherapy. 2017 May;37(5):555-578
pubmed: 28258648